Identify the genetic basis of myopathies
Subgroup Leader : Valérie BIANCALANA
We study rare and severe neuromuscular disorders caused by mutations in proteins controlling intracellular organization and dynamics. We aim to tackle the three main bottlenecks in this field:
.jpg)
Identify the genetic basis of myopathies, myalgia and high athletic performances
Project leaders : Valérie BIANCALANA, Johann BOHM, Jocelyn LAPORTE
Understand and cure myotubular/centronuclear myopathies through gene modulation and pharmacology
Project leader : Jocelyn LAPORTE
Understand and cure tubular aggregates myopathy and Stormorken syndrome through gene modulation and pharmacology
Project leader : Johann BOHM
Subgroup Leader : Valérie BIANCALANA
Subgroup Leader : Jocelyn LAPORTE
Article in a journal
International Journal of Molecular Sciences ; Volume: 22 ; Page: 11377
Article in a journal
Molecular Therapy
Article in a journal
Genes ; Volume: 12 ; Page: 1199
Article in a journal
Clinical Genetics ; Volume: 100 ; Page: 234 - 235
Article in a journal
Cells ; Volume: 10 ; Page: 1730
Pre-publication, Working Document
Article in a journal
Journal of Medical Genetics ; Volume: 59
Article in a journal
neurogenetics ; Volume: 22 ; Page: 33-41
Article in a journal » Review article
Autophagy ; Volume: 17 ; Page: 1-382
Article in a journal
Molecular Therapy
Current fundings:

On February 27, the IGBMC opened its doors to several members of the Unistra Alumni Network, led by Agnès Villanueva (Director of Alumni Relations),…
Read more
Follow our publications and latest research on Researchgate : www.researchgate.net/profile/Jocelyn-Laporte
Raw data for our study on Multi-omics comparisons of different forms of centronuclear myopathies and the effects of several therapeutic strategies. Mol Ther. 2021 Apr 30:S1525-0016(21)00247-1.
www.ncbi.nlm.nih.gov/geo/query/acc.cgi
www.sciencedirect.com/science/article/abs/pii/S1525001621002471
In the press: